Siemens Healthineers’s CLINITEST COVID-19 Antigen Test Receives the US FDA's EUA for the Prevention of COVID-19
Shots:
- The US FDA has issued a EUA for the CLINITEST Rapid COVID-19 Antigen Self-Test in individuals aged ≥14yrs. The company provides access globally to a new self-test for individuals, families, and businesses to prevent COVID-19
- The nasal swab test helps for the rapid detection of SARS-CoV-2 which is expected to be available in January & provides the results in just 15 min.
- The product is highly accurate with 86.5% sensitivity and a specificity of 99.3% compared to the nucleic acid (PCR) detection method. Additionally, clinical data has been established under Siemens Healthineers participation in the NIH RADx Independent Test Assessment Program (ITAP)
Ref: Businesswire | Image: Siemens
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com